A second series of four variants of PR8-S virus has been produced by passage of the variants in the lungs of mice immunized with the PR8-S virus as well as the homologous strain. The PR8-S virus was added as a constant component of the vaccine so that a high antibody titer to it would suppress selectively the development of variants with PR8-S characteristics. Comparative H.I. and in ovo neutralization tests with the first and second series of variants revealed that the three variants, Fd/s, Gf/s, and Hg/s, of the second series, failed to react with PR8-S antisera and produced significantly smaller amounts of antibody which reacted with PR8-S, the variants of the first series, and the first variant (D/s) of the second series. Although these three variants reacted quite similarly in the H.I. and neutralization tests cross-absorption of these sera with the PR8-S virus and themselves revealed individual antigenic characteristics. While these studies emphasize the importance of the immune state of the host the precise mechanism in the selection of a new antigenic component in the emerging variant must yet be determined.

This content is only available as a PDF.